Coronary microvascular dysfunction.
暂无分享,去创建一个
[1] M. Rubens,et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. , 2009, European heart journal.
[2] W. Lawson,et al. Enhanced external counterpulsation is an effective treatment for Syndrome X. , 2009, International journal of cardiology.
[3] Mutlu Hayran,et al. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. , 2009, Atherosclerosis.
[4] L. Lerman,et al. Lack of Correlation Between Noninvasive Stress Tests and Invasive Coronary Vasomotor Dysfunction in Patients With Nonobstructive Coronary Artery Disease , 2009, Circulation. Cardiovascular interventions.
[5] Carl J Pepine,et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.
[6] A. Phan,et al. Persistent chest pain and no obstructive coronary artery disease. , 2009, JAMA.
[7] C. Lang,et al. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. , 2009, Cardiovascular therapeutics.
[8] E. Picano,et al. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. , 2009, The American journal of cardiology.
[9] E. Ernst,et al. Autogenic training to manage symptomology in women with chest pain and normal coronary arteries , 2009, Menopause.
[10] J. Seward,et al. Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobutamine stress echocardiography. , 2008, The American journal of cardiology.
[11] Sonia S. Anand,et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. , 2008, European heart journal.
[12] B. Tuccillo,et al. Factors predicting coronary flow reserve impairment in patients evaluated for chest pain: An ultrasound study , 2008, Journal of cardiovascular medicine.
[13] H. Gullu,et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. , 2008, Atherosclerosis.
[14] Filippo Crea,et al. Coronary microvascular dysfunction. , 2013, The New England journal of medicine.
[15] G. Hasenfuss,et al. Mechanism of action of the new anti-ischemia drug ranolazine , 2007, Clinical Research in Cardiology.
[16] H. Gullu,et al. Effects of Atorvastatin on Coronary Flow Reserve in Patients with Slow Coronary Flow , 2007, Clinical cardiology.
[17] S. Reis,et al. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) , 2007, Clinical cardiology.
[18] W. Ferrell,et al. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. , 2006, Journal of the American College of Cardiology.
[19] Nikolaus Marx,et al. Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[20] L. Shaw,et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[21] Michael C. McDaniel,et al. Diets and cardiovascular disease: an evidence-based assessment. , 2005, Journal of the American College of Cardiology.
[22] Pascal Meier,et al. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. , 2005, Journal of the American College of Cardiology.
[23] C Noel Bairey Merz,et al. Angina with "normal" coronary arteries. , 2005 .
[24] A. Zeiher,et al. Endothelial Function: Cardiac Events , 2005, Circulation.
[25] Dudley J Pennell,et al. Adjunctive role of cardiovascular magnetic resonance in the assessment of patients with inferior attenuation on myocardial perfusion SPECT. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[26] A. Zeiher,et al. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome , 2004, Coronary artery disease.
[27] K. Smith,et al. Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.
[28] C. Pizzi,et al. Angiotensin-Converting Enzyme Inhibitors and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Cardiac Syndrome X: Role of Superoxide Dismutase Activity , 2004, Circulation.
[29] C. Lowenstein,et al. L-Arginine Ameliorates the Abnormal Sympathetic Response of the Dysfunctional Human Coronary Microvasculature , 2004, Angiology.
[30] 松田 康章. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease , 2004 .
[31] G. Adler,et al. Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ NG-Nitro-l-Arginine Methyl Ester-Induced Myocardial Injury , 2003, Circulation.
[32] Pawe,et al. Transthoracic Doppler echocardiography – noninvasive diagnostic window for coronary flow reserve assessment , 2003, Cardiovascular ultrasound.
[33] S. Reis,et al. Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. , 2003, American heart journal.
[34] E. Porteri,et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. , 2003, Journal of hypertension.
[35] M. Pfisterer,et al. Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[36] Hiroaki Shimokawa,et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. , 2003, Journal of the American College of Cardiology.
[37] A. Struthers,et al. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. , 2002, Clinical science.
[38] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[39] K. Eagle,et al. Frequency of negative coronary arteriographic findings in patients with chest pain is related to community practice patterns. , 2002, The American journal of managed care.
[40] Z. Ungvari,et al. Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function , 2002, Circulation research.
[41] Onathan R. P Anting,et al. ABNORMAL SUBENDOCARDIAL PERFUSION IN CARDIAC SYNDROME X DETECTED BY CARDIOVASCULAR MAGNETIC RESONANCE IMAGING , 2002 .
[42] Pepine,et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. , 2001, American heart journal.
[43] O. Rimoldi,et al. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. , 2001, Cardiovascular research.
[44] F. Crea,et al. Spinal cord stimulation in patients with refractory anginal pain and normal coronary arteries. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.
[45] J. Knuuti,et al. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. , 2001, Clinical physiology.
[46] T. Lüscher,et al. Coronary Heart Disease in Smokers: Vitamin C Restores Coronary Microcirculatory Function , 2000, Circulation.
[47] B. Strauer,et al. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. , 2000, Hypertension.
[48] J. Manson,et al. Primary prevention of coronary heart disease in women through diet and lifestyle. , 2000, The New England journal of medicine.
[49] A M Zeiher,et al. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.
[50] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[51] G. Rosano,et al. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance. , 1999, Cardiologia.
[52] M. Yazici,et al. The effect of aminophylline infusion on the exercise capacity in patients with syndrome X. , 1999, Acta cardiologica.
[53] A. Maseri,et al. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. , 1999, The American journal of cardiology.
[54] S. Iliceto,et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. , 1999, Journal of the American College of Cardiology.
[55] M A Horsfield,et al. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. , 1999, Journal of the American College of Cardiology.
[56] S. Higano,et al. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. , 1998, Mayo Clinic proceedings.
[57] S. Higano,et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. , 1998, Circulation.
[58] J. Kaski,et al. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. , 1998, European heart journal.
[59] T. Lehtimäki,et al. Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.
[60] T. Lüscher,et al. Structure and reactivity of small arteries in aging. , 1998, Cardiovascular research.
[61] E Fleck,et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). , 1997, Circulation.
[62] R. Gibbons,et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.
[63] P. Elliott,et al. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). , 1997, Heart.
[64] T. Imaizumi,et al. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. , 1997, Circulation.
[65] M. Omata,et al. Reduced coronary flow reserve in familial hypercholesterolemia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] A. Takeshita,et al. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. , 1996, Circulation.
[67] O. Hess,et al. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. , 1995, International journal of cardiology.
[68] M. J. Davis,et al. Longitudinal gradients for endothelium-dependent and -independent vascular responses in the coronary microcirculation. , 1995, Circulation.
[69] A. Zeiher,et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. , 1995, Circulation.
[70] O Muzik,et al. Early Detection of Abnormal Coronary Flow Reserve in Asymptomatic Men at High Risk for Coronary Artery Disease Using Positron Emission Tomography , 1994, Circulation.
[71] A. Quyyumi,et al. Imipramine in patients with chest pain despite normal coronary angiograms. , 1994, The New England journal of medicine.
[72] B. Strauer,et al. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. , 1993, Circulation.
[73] M. Sugimachi,et al. Effects of Age on Endothelium‐Dependent Vasodilation of Resistance Coronary Artery by Acetycholine in Humans , 1993, Circulation.
[74] D. Stewart,et al. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors. , 1993, The Canadian journal of cardiology.
[75] M. Marcus,et al. Effects of nitroglycerin on the coronary microcirculation in normal and ischemic myocardium. , 1992, Journal of cardiovascular pharmacology.
[76] K. Murray,et al. Cyclic AMP and mechanisms of vasodilation. , 1990, Pharmacology & therapeutics.
[77] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[78] R. Cannon,et al. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. , 1985, The American journal of cardiology.
[79] E. Sowton,et al. CLINICAL FEATURES AND FOLLOW-UP OF PATIENTS WITH ANGINA AND NORMAL CORONARY ARTERIES , 1976, The Lancet.
[80] R Gorlin,et al. The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. , 1973, The American journal of medicine.
[81] A. K. Rogers,et al. Long‐Term Observations in Patients with Angina and Normal Coronary Arteriograms , 1972, Circulation.
[82] I. Valenta,et al. Quantification of myocardial blood flow with 82 Rb positron emission tomography : clinical validation with 15 O-water Prior , 2022 .